Treatment of Childhood Acute Lymphoblastic Leukemia
Status:
Terminated
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to reduce the side-effects and discomfort of anti-leukemia
therapy, to attain long-term control of the disease and to hopefully eradicate it.
Phase:
Phase 3
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Boston Children's Hospital Boston Children’s Hospital